Skip to main content
Clinical Trials/NCT01872273
NCT01872273
Withdrawn
N/A

Blood Cell Response to Exercise

USDA Grand Forks Human Nutrition Research Center0 sitesFebruary 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
USDA Grand Forks Human Nutrition Research Center
Primary Endpoint
Platelet Reactivity
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

Moderate exercise is recommended to improve cardiovascular health in obese and overweight people particularly with metabolic syndrome (MetS) that have hypertension, elevated fasting blood sugar, and elevated blood lipids. This study is being done to determine how platelets respond when a person performs an initial period of moderate exercise.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
June 2016
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
USDA Grand Forks Human Nutrition Research Center
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 30-60 years old
  • BMI \>/=26 and \<40 kg/m2
  • not planning to or currently attempting to gain or lose weight
  • low reported omega-3 fatty acid intake per Omega-3 Checklist
  • Metabolic Syndrome as define 3/5 of the following:Waist circumference: men \> 102 cm women \> 88 cm, triglycerides \> 150 mg/dL, HDL cholesterol: men \< 40 mg/dL women \< 50 mg/dL,Blood pressure \>130/\>85 mmHg,Fasting glucose \> 100 mg/dL (Hypertensive subjects are eligible if taking thiazide diuretics NOT ACE inhibitors beta blockers)

Exclusion Criteria

  • smoke or use tobacco or nicotine in any form (including pills and patches)
  • take any medication that makes you unable to exercise
  • have established cardiovascular, pulmonary, and/or metabolic disease such as diabetes
  • have uncontrolled hypertension
  • have alcohol, anabolic steroid, or other substance abuse issues
  • consume more than 3 alcoholic drinks/week
  • have joint or muscle injuries that affects your ability to exercise
  • have cancer (other than skin cancer or carcinoma in situ of the cervix
  • pregnant or lactating
  • currently exercise regularly

Outcomes

Primary Outcomes

Platelet Reactivity

Time Frame: Baseline, post-intervention (24 hours), & time points during the exercise phase: prior to exercise (-25 min, -10 min, - 1 min), 10 minutes into the routine, at completion (25 minutes), and 20 & 60 minutes following completion

We hypothesize that moderate physical exercise will increase platelet reactivity in sedentary individuals with metabolic syndrome. Platelet reactivity will be measured by flow cytometry using anti-CD61 antibodies as a marker for platelets and anti-CD62 (P-selectin) as a marker of platelet activation. This will be measured at baseline, post-intervention and time points post-baseline in each subject.

Similar Trials